MFDS — authorised 23 November 2020
- Marketing authorisation holder: ALNYLAM PHARMS INC
- Status: likely_approved
🇰🇷 Oxlumo in South Korea
MFDS authorised Oxlumo on 23 November 2020
Marketing authorisation
Oxlumo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Oxlumo approved in South Korea?
Yes. MFDS authorised it on 23 November 2020.
Who is the marketing authorisation holder for Oxlumo in South Korea?
ALNYLAM PHARMS INC holds the South Korean marketing authorisation.